Neauvia Stimulate Man is a CE-marked injectable dermal filler developed for professional aesthetic treatments, specifically formulated with consideration for the structural characteristics of male skin. Male skin is typically thicker, denser, and richer in collagen fibers, which requires fillers with appropriate rheological and volumising properties.
The product combines cross-linked hyaluronic acid with calcium hydroxyapatite (CaHA) and selected amino acids, offering both immediate tissue support and gradual biostimulation. The hyaluronic acid is stabilised using PEG (polyethylene glycol) IPN technology, designed to provide hydration and structural support in the mid to deep dermal layers. Calcium hydroxyapatite microspheres are used to support tissue firmness and are known to promote collagen synthesis as part of the body’s natural regenerative response.
Neauvia Stimulate Man has a medium-density, cohesive gel consistency that allows controlled injection, even distribution in the tissue, and stable integration without excessive volumisation. The formulation is designed to adapt to facial movements while maintaining natural-looking contours.
Neauvia Stimulate Man is intended for use in adult male patients as part of aesthetic procedures aimed at improving skin quality and facial contours while preserving masculine facial features.
Typical treatment goals include:
- restoration of soft tissue volume
- improvement of skin firmness and elasticity
- reduction in the appearance of moderate to deep wrinkles and folds
- support of facial contours affected by age-related volume loss
- improvement of skin texture and overall appearance
Observed effects may include:
- immediate volumising effect from the hyaluronic acid component
- gradual improvement in skin structure due to collagen stimulation
- smoother skin surface and more defined facial contours
The product may be used in areas such as the forehead, glabellar region, nasolabial folds, cheeks, cheekbones, perioral area, neck, and dorsal hands. Treatment protocol, injection depth, and number of sessions are determined exclusively by the treating medical professional based on individual patient characteristics.
Depending on patient-specific factors and treatment technique, results may persist for approximately 12–15 months.